Connell Consulting
Essential reading for the healthcare business
 
 
Remember me:
Skip Navigation LinksHealthInvestor article
Interserve-led consortium left as final bidder for cancer contract

A consortium led by Interserve Investments is the only remaining bidder for the £687 million contract to provide cancer services in Staffordshire.

Interserve Investments’ consortium also includes The Royal Wolverhampton Hospitals NHS Trust and the University Hospitals of North Midlands NHS Trust.

The two trusts were originally each separate bidders and among the five parties who made it through the pre-qualification stage for the contract before teaming up with Interserve Investments.

CSC Computer Sciences and United Health UK were the other two organisations to pre-qualify. Both, however, pulled out of the process.

In a statement to HSJ, the clinical commissioning groups tendering the contract said: "During the competitive dialogue with bidders on the programme, a number of individual organisations and providers came together and formed a bidding consortium.

"This brings together the public and private sector, including two local NHS trusts.

"It will bring together a wide range of skills and expertise to implement this innovative approach to the commissioning of cancer care.

"The consortium is the last remaining bidder."

The consortium has to submit a formal proposal over the next few months before the contract is awarded in December.

The cancer services contract is one half of a wider procurement process, worth £1.2 billion in total, being carried out by the four local clinical commissioning groups (CCGs). An end-of-life contract, with a value of £535 million, is also being tendered out.

Cannock Chase CCG, North Staffordshire CCG, Stafford & Surrounds CCG and Stoke-on-Trent CCG are the four CCGs tendering out the two contracts.

NHS Strategic Projects Team is running the process.


Related articles:

Posted on: 04/06/2015

Latest news stories

21/08/2017
Councils have been warned that they must reduce hospital bed blocking by next month – in some cases by up to 70% – or face cuts to funding.
21/08/2017
Bridges Fund Management partner Garret Turley has left the firm after six years to join August Equity.
17/08/2017
Health tech start-up Medopad, which is backed by pharma company Bayer, intends to raise $30 million (£29.3 million) in private investment.
15/08/2017
Corby Clinical Commissioning Group has been ordered to recompense an independent provider after it failed to pay the full NHS tariff over several years.
15/08/2017
Project Phoenix, the plan to establish six public-private partnerships to dispose of unneeded NHS assets, is expected to be receive government approval within weeks.


Civica


politics

After a dramatic election result, Ploy Radford asks what our new government means for health and social care
Read more


HealthInvestor Events


public-private partnership
Sarah Williams weighs up the public-private partnership models driving change in health and social care
Read more


Christie + Co

HealthInvestor App


charity profile

Waymarks is tackling the more challenging end of the adult learning disabilities sector. Ploy Radford reports
Read more



interview - David McKinney

Real integration of health and care means throwing housing and technology into the bargain too, according to Tunstall's David McKinney. Sarah Williams hears more
Read more



HealthInvestor blog
The outgoing chief inspector of hospitals may not think the NHS necessarily needs more money to do things better, but social care does if it is to help the health service with bed blocking

Click here to view the Editor's blog


Howard de Walden Estate chief executive Andrew Hynard has his hands on a £1.1 billion medical portfolio steeped in the history of Harley Street. But staying relevant means keeping a finger firmly on the pulse of innovation, he tells Sarah Williams
HealthInvestor UK catches up with Professor Takanori Shibata and his robotic creation PARO, 15 years after it first entered care homes, to find out how the fluffy seal is advancing care
Managing director at Regard Group
Clare Connell and Henry Hunt of Connell Consulting investigate the implications of the opiate and prescription-only medicines addiction in the UK
Candesic’s Dr Joe Taylor considers the implications of the UK’s shortage of doctors

Click here to search all feature articles